Procedure options in medical abortion
Gynmed Ambulatorium, Vienna, Austria
Mifepristone has been approved for more than 15 years now.
Surprisingly and in contrast to other treatments in medicine, the regimen for
medical abortion has undergone only minor improvements during that time.
The following treatment option in the practise of medical
abortion will be presented:
Option of home use of misoprostol
Is there a lower or upper limit in gestational age?
Is there a need for giving Rh-immunoglobulins to Rh-negative
women in very early medical abortion?
Improving pain treatment including the use of NSAIDs
How to verify expulsion: Ultrasound or hCG?
Restrictions in access to abortion in the European
perspective: where is the evidence?
Making abortion practice truly evidence based and integrating
these findings into current practise would improve women’s health status, give
them more autonomy in the abortion process and would reduce medical supervision
wherever it has been shown to be unnecessary.